HF
DXCM icon

HRT Financial’s DexCom DXCM Stock Holding History

HRT Financial’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$973K Sell
15,500
-12,000
-44% -$836K ﹤0.01% 2079
2025
Q4 		$1.82M Buy
27,500
+5,100
+23% +$330K 0.01% 1366
2025
Q3 		$1.51M Buy
+22,400
New +$1.77M 0.01% 1311
2025
Q2 		– Sell
-3,300
Closed -$225K – 2831
2025
Q1 		$225K Buy
+3,300
New +$269K ﹤0.01% 1940
2023
Q4 		– Sell
-16,000
Closed -$1.49M – 2473
2023
Q3 		$1.49M Buy
+16,000
New +$1.8M 0.01% 764
2023
Q1 		– Sell
-6,800
Closed -$770K – 2641
2022
Q4 		$770K Buy
+6,800
New +$747K 0.01% 1124
2022
Q2 		– Sell
-29,600
Closed -$3.79M – 3094
2022
Q1 		$3.79M Buy
29,600
+13,600
+85% +$1.49M 0.03% 371
2021
Q4 		$2.15M Sell
16,000
-27,600
-63% -$3.97M 0.01% 621
2021
Q3 		$5.96M Buy
+43,600
New +$5.5M 0.04% 274

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HRT Financial's DXCM Position: Q1 2026 in Review

HRT Financial sold out of DexCom (DXCM) in Q1 2026, closing a stake of 3,810 shares — an estimated $265K sold.

HRT Financial first reported a position in DXCM in Q3 2018 and held it in 14 quarters. The position peaked at $22.3M in Q4 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • HRT Financial reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 3,810 DexCom shares in Q1 2026, an estimated $265K.
  • HRT Financial first reported a position in DexCom in Q3 2018 and held it in 14 quarters.
  • HRT Financial's DexCom position peaked at $22.3M in Q4 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.